Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0D0SC
|
|||
| Former ID |
DNC014211
|
|||
| Drug Name |
6-Hydroxy-N-(2-morpholinoethyl)nicotinamide
|
|||
| Synonyms |
6-Hydroxy-N-(2-morpholinoethyl)nicotinamide; CHEMBL596971; BDBM50307189; AKOS008932018; AKOS027598195
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C12H17N3O3
|
|||
| Canonical SMILES |
C1COCCN1CCNC(=O)C2=CNC(=O)C=C2
|
|||
| InChI |
1S/C12H17N3O3/c16-11-2-1-10(9-14-11)12(17)13-3-4-15-5-7-18-8-6-15/h1-2,9H,3-8H2,(H,13,17)(H,14,16)
|
|||
| InChIKey |
BNPSDTRXYVPPCU-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Design of novel nicotinamides as potent and selective monoamine oxidase a inhibitors. Bioorg Med Chem. 2010 Feb 15;18(4):1659-64. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.